Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Altimmune just shared some encouraging news. Its experimental drug pemvidutide helped people cut back on heavy drinking in a mid-stage clinical trial. And the results looked strong enough to turn heads on Wall Street. The company ran the study, called…
A recent clinical trial brings new hope for addiction treatment today. Researchers recently tested a popular weight loss medication called semaglutide. They wanted to see if it reduces heavy drinking habits safely. Furthermore, they specifically focused on adults with both…
A recent study published in eBioMedicine highlights new behavioral findings. Researchers report that tirzepatide substantially reduced alcohol consumption in rodent models. The medication also curtailed binge drinking and relapse behavior. Consequently, these findings expand evidence linking intestinal peptides to addiction…